Flowchem Pharma Private Limited - Due diligence report

A 360° intelligence report on Flowchem Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and…

2018-11-12 Bangalore, Karnataka Active Unlisted
Share
Connect MCP
FP Flowchem Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Flowchem Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
68/100
Trust Score
Moderate

Flowchem Pharma Private Limited is assessed as Moderate with a Trust Score of 68/100. Flowchem Pharma Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 26 Jul 2026 from the latest processed filings. Flowchem Pharma Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
81/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
30/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Working-capital cover adequate.

Charges position: 1 open (15.00 cr) · 1 satisfied (12.50 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
State Bank Of India1 48.0 cr
Compliance Score: 81/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
  • 2 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
DIPAK KUMAR CHAUDHARY 01234567 Director 01/04/2018 6 yrs Approved
ANJAN KUMAR ROY 01234567 Director 01/04/2018 6 yrs Approved
TRISHNA ROY 01234567 Director 01/04/2018 6 yrs Approved
Parthasarathi Pal 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 4 transfer(s)

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 70
Growth signals & trust indicators
Latest year revenue grew 1.42.
Asset base grew 2.1x - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 7 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Negative net worth.
1 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment50/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 15.00 cr already registered.
  • Compliance record supports lending.
Investor view56/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
04 Jul 2025
Charge created
Others - 15.00 cr
24 Jun 2025
Director appointed
Parthasarathi Pal (Director)
30 Sep 2024
Last AGM held
Annual general meeting
12 Sep 2024
Director ceased
ARUN GUNWANTRAO BIRADAR
31 Mar 2024
Share transfer (FY 2024)
550000.00000000 shares to TRISHNA ROY
Share transfer (FY 2024)
450000.00000000 shares to TRISHNA ROY
Share transfer (FY 2024)
10000.00000000 shares to TRISHNA ROY
Latest balance sheet
Filed with ROC
08 Jul 2023
Director ceased
MRINMOY ROY
15 Jun 2023
Director appointed
TRISHNA ROY (Director)
14 Jun 2022
Charge satisfied
State Bank Of India
06 Sep 2021
Director appointed
ANJAN KUMAR ROY (Director)
27 Aug 2021
Securities allotted
700000 Equity Shares - 70.00 Lakh raised
08 Jul 2021
Securities allotted
1700000 Equity Shares - 1.70 cr raised
10 May 2021
Securities allotted
600000 Equity Shares - 60.00 Lakh raised
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold the largest single block of equity as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sain Medicaments U24230TG1983PTC004015 Ap, Telangana, India
Danashmand Organic Private Limited U24100MH1999PTC118647 Mumbai, Maharashtra, India
Aarux Pharmaceuticals Private Limited U51397TN2006PTC059075 Chennai, Tamil Nadu, India
Farbe Firma U24100GJ2021PTC123062 Ankleshwar, Gujarat, India
Truelixir Life Science Private Limited U74999MH2018PTC308831 Aurangabad, Maharashtra, India
Vxldrugs U24239DL2000PTC104382 Delhi, Delhi, India
Hbc Healthcare Private Limited U51909GJ2020PTC118120 Gandhinagar, Gujarat, India
Parthiv Global Industries Private Limited U14200RJ2016PTC054834 Jaipur, Rajasthan, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Flowchem Pharma Private Limited before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Flowchem Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Flowchem Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Flowchem Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Flowchem Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Flowchem Pharma Private Limited an active company?

Flowchem Pharma Private Limited has MCA status “Active” with a compliance score of 81/100 (Low Risk).

Is Flowchem Pharma Private Limited financially healthy?

Flowchem Pharma Private Limited has a Financial Health Score of 30/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Flowchem Pharma Private Limited?

Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Flowchem Pharma Private Limited?

Promoters hold the largest single block of equity - exact percentages are in the full report. 4 active director(s) are on record.

Does Flowchem Pharma Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Flowchem Pharma Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 81/100 (Low Risk).

Is it risky to lend to Flowchem Pharma Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.